Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-760760e67b986477: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-c2b96ac534087171: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-75168051de78c712: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-f3d5563dbc6127c5: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-ace72147ea048bb1: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-7dde4823a27b6f89: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-14c0e2f551bc3f25: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-0e948ed2227bb4f5: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-1794b53cc398e1be: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-4b647c09cb26ffe8: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-760760e67b986477
- pantheon_debate:pd-c2b96ac534087171
- pantheon_debate:pd-75168051de78c712
- pantheon_debate:pd-f3d5563dbc6127c5
- pantheon_debate:pd-ace72147ea048bb1
- pantheon_debate:pd-7dde4823a27b6f89
- pantheon_debate:pd-14c0e2f551bc3f25
- pantheon_debate:pd-0e948ed2227bb4f5
- pantheon_debate:pd-1794b53cc398e1be
- pantheon_debate:pd-4b647c09cb26ffe8
Context
{"topic":"general","source_refs":["pantheon_debate:pd-760760e67b986477","pantheon_debate:pd-c2b96ac534087171","pantheon_debate:pd-75168051de78c712","pantheon_debate:pd-f3d5563dbc6127c5","pantheon_debate:pd-ace72147ea048bb1","pantheon_debate:pd-7dde4823a27b6f89","pantheon_debate:pd-14c0e2f551bc3f25","pantheon_debate:pd-0e948ed2227bb4f5","pantheon_debate:pd-1794b53cc398e1be","pantheon_debate:pd-4b647c09cb26ffe8"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10